Vasopressor Therapy
Jean-Louis Vincent1, Filippo Annoni1
1Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, 1070 Brussels, Belgium.
Journal of Clinical Medicine
|December 17, 2024
Summary
Vasopressor therapy is crucial for managing shock patients by maintaining vascular tone and tissue perfusion. Norepinephrine is the first-line choice, but individualized treatment considering hemodynamic response is key for effective vasopressor use.
Area of Science:
- Critical Care Medicine
- Pharmacology
- Hemodynamics
Background:
- Vasopressor therapy is essential for intensive care patients experiencing shock.
- Maintaining adequate tissue perfusion is a primary goal in managing shock.
- Norepinephrine is the recommended first-line vasopressor due to its efficacy and safety profile.
Purpose of the Study:
- To review different vasopressor agents used in intensive care.
- To emphasize tailoring vasopressor therapy to individual patient needs and hemodynamic responses.
- To discuss the role of various vasoactive agents in managing shock.
Main Methods:
- This study is a narrative review.
- It synthesizes current literature on vasopressor agents.
- Focuses on clinical application and patient-specific considerations.
Main Results:
- Norepinephrine offers reliable vasoconstriction with minimal heart rate impact and mild inotropic effects.
- Vasopressin and angiotensin II have roles in specific vasodilatory states or high renin conditions, requiring further data.
- Dobutamine aids tissue perfusion when oxygen delivery is reduced, often with continued fluid administration.
Conclusions:
- Individualized vasopressor selection and titration based on hemodynamic response are critical for optimal patient outcomes.
- Avoiding excessive vasoconstriction is paramount when using any vasopressor agent.
- A comprehensive understanding of different vasoactive agents allows for targeted therapy in shock management.
Related Concept Videos
01:23Antihypertensive Drugs: Vasodilators
474
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
474
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
382
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
01:22Heart Failure Drugs: β-Blockers
315
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
315
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
171
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
171
01:30Adrenergic Agonists: Therapeutic Uses
725
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
725
01:22Heart Failure Drugs: Diuretics
339
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339